Low dose etodolac in rheumatoid arthritis: A review of early studies

Journal of Rheumatology

Volumn 24, Issue SUPPL. 47, 1997, Pages 3-9

  Spencer Green, George ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Etodolac; Human; Nonsteroidal antiinflammatory agents; Rheumatoid arthritis

Indexed keywords

ETODOLAC; NONSTEROID ANTIINFLAMMATORY AGENT; ACETYLSALICYLIC ACID; PIROXICAM; PLACEBO; SULINDAC;

ARTICLE; CLINICAL TRIAL; HUMAN; META ANALYSIS; RHEUMATOID ARTHRITIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; TINNITUS; VOMITING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; ETODOLAC; HUMANS;

EID: 0031042094     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Vetter G, Placchi M, Joubert L: Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients. Int J Clin Pharmacol Ther Toxicol 1982;20:240-5.
2. Neustadt DH: Double blind evaluation of the longterm effects of etodolac versus ibuprofen in patients with rheumatoid arthritis. J Rheumatol 1997;(suppl 47)24:17-22.
3. Jacob G, Messina M, Kennedy J, Epstein C, Sanda M, Mullane J: Minimum effective dose of etodolac for the treatment of rheumatoid arthritis. J Clin Pharmacol 1986;26:195-202.
4. Jacob GB, Hart KK, Mullane JF, Lutins S, Lee TY: Placebo-controlled study of etodolac and aspirin in the treatment of rheumatoid arthritis. Curr Ther Res 1983;33:703-13.
5. Edwards W: Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: A 12-week study. Clin Ther 1983;5:495-503.
6. del Toro RA, Concepción R: Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis. Clin Ther 1983;5:436-44.
7. Dick WC, Franchimont P, Veys E: Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis. Clin Ther 1993;15:148-59.
8. Briançon D, Peterschmitt J, Laviec G: Double-blind parallel-group evaluation of the safety and efficacy of etodolac capsules compared with piroxicam capsules in patients with rheumatoid arthritis. Acta Therapeutica 1991;17:35-47.
9. Schattenkirchner M: Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis. Curr Med Res Opin 1991;12:497-506.
10. Lonauer G, Tisscher JR, Lim HG, Bijlsma JWJ: Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis. Curr Med Res Opin 1993;13:70-7.
11. Waltham-Weeks CD: Etodolac versus naproxen in rheumatoid arthritis: A double-blind crossover study. Curr Med Res Opin 1987;10:540-7.